Granulomas are organized aggregates of immune cells defined by the presence of macrophages, with a variety of other features (i.e. necrosis and fibrosis) being more variable (Warren, 1976). The evolved function of the granuloma response is thought to be a protective mechanism by which immune cells sequester a foreign body or pathogen, walling-off the threat (Pagán and Ramakrishnan, 2018). Some pathogens are not successfully eliminated, however, leading to chronic granulomas that persist for months or sometimes even years. New in vivo models are needed to study the complicated mechanisms that coordinate the formation of protective granulomas, in order to understand the events that lead to the successful clearance of pathogens that initiate this response.

We seek to identify environmental pathogens that have immense virulence capacity but are defeated by the innate immune system. Chromobacterium violaceum is one such pathogen that invades host cells and replicates in the intracellular niche, but only causes morbidity and mortality in immunocompromised animals or individuals (Macher, 1982). We discovered that during infection, wildtype (WT) C57BL/6 mice develop necrotic liver granulomas in response to this ubiquitous soil microbe (Harvest et al., 2023; Maltez et al., 2015). As soon as 1 day post-infection (1 DPI), liver microabscesses can be macroscopically visualized. These lesions are composed primarily of neutrophils until approximately 3–5 DPI, when, importantly, monocytes traffic into the area and form a mature granuloma starting at 5 DPI. Once the resulting macrophage zone surrounds the infected lesion, bacterial burdens begin to decrease, suggesting that granuloma macrophages are an important cell type for the clearance of C. violaceum. By 21 DPI, virtually all mice clear the infection and resolve the granuloma pathology, leaving small collagen scars in place of lesions (Harvest et al., 2023). Though we identified neutrophils and macrophages as the key immune players in this model, much remains to be learned about the cellular mechanisms that initiate formation of the granuloma in response to C. violaceum, and what signals instruct immune cells to organize within the granuloma architecture. Indeed, by studying the granuloma response that successfully clears C. violaceum, we hope to identify critical cellular mechanisms that underlie the basic biology of the granuloma response.

Within the granuloma response to C. violaceum, neutrophils and then macrophages migrate and assemble in an organized manner. Cellular movement, or chemotaxis, must be carefully regulated during tissue development, homeostasis, and inflammatory responses (Hughes and Nibbs, 2018). Chemotaxis is controlled by small, secreted proteins called chemokines that signal through transmembrane chemokine receptors. Since their discovery in the 1980s, approximately 50 chemokines are now appreciated for their role in cellular chemotaxis (Zlotnik and Yoshie, 2012). The temporal and spatial expression of chemokines and chemokine receptors dictate cellular trafficking, and dysregulation of these systems is linked to many diseases (Turner et al., 2014).

As more chemokines have been identified, there have been multiple revisions to their nomenclature, and now a systematic naming of chemokines and their receptors is in wide use. Chemokines have conserved cysteine residues, and the current naming system categorizes four subfamilies based on the arrangement of these N-terminal cysteines: CXC, CC, XC, and CX₃C (Zlotnik and Yoshie, 2000). Though there are exceptions, most chemokines fit into one of these four subfamilies. Similarly, chemokine receptors fall into four subfamilies based on their chemokine ligand. The naming scheme has become complicated due to promiscuous ligand–receptor interactions, reassigning of mouse and human homologs after syntenic analysis, and divergent evolution of ligands in mice and humans (Nomiyama et al., 2013). Nonetheless, the detailed description of many chemokines and their receptors has been accomplished in both species. Herein, we focus on the mouse chemokines and their role in the C. violaceum-induced murine granuloma.

Inflammatory chemokines are those that are rapidly upregulated in the presence of infection or other inflammatory stimuli (David and Kubes, 2019). Several cell types can upregulate chemokines, creating a gradient of ligand that diffuses away from the point of infection. Still other cell types can respond to this gradient if/when they express the appropriate receptor. Furthermore, activated cells that migrate to the area can also upregulate expression of chemokines, creating a feed-forward loop to enhance cell recruitment. In addition to mediating chemotaxis, chemokines can induce a variety of other cellular responses including proliferation, oxidative burst, and even degranulation (Hughes and Nibbs, 2018). Lastly, it is now appreciated that chemokines also contribute to wound healing and resolution of inflammation, with coordinated efforts between neutrophils and macrophages to clean up debris and halt immune cell infiltration (Soehnlein and Lindbom, 2010).

Here, we use spatial transcriptomics to identify key genes that are upregulated in response to C. violaceum, and assess the importance of CCR2-dependent monocyte trafficking to the site of infection in the liver.

Here, we demonstrate that macrophages are essential for clearance of C. violaceum from the infected liver, and for protection against dissemination into the spleen. Loss of CCR2-dependent monocyte trafficking results in a loss of bacterial containment, ultimately leading to uncontrolled bacterial replication in the liver, evidenced by elevated CFU burdens and increased lesion size.

There are many questions that still remain about the individual and coordinated efforts of neutrophils and macrophages during infection with C. violaceum. It is likely that the tissue-resident Kupffer cells and infected hepatocytes are the first cells to sound the alarm, calling for neutrophils. The initial recruitment of neutrophils likely involves chemokines (i.e. CXCL1 and CXCL2) redundantly with other chemoattractants such as formylated peptides and leukotrienes. However, these neutrophils are unable to clear the infection despite being recruited in large numbers.

Based on our data, CCR2 is an essential chemokine receptor for monocyte trafficking in response to C. violaceum, but we have not yet determined which ligand(s) mediate this response. CCL2 and CCL7 can both bind to CCR2 to induce monocyte trafficking. Importantly, pro-inflammatory cytokines and PAMPs can induce CCL2 expression by most cell types (Shi and Pamer, 2011). In agreement, we see upregulation of Ccl2 in several clusters and deposition of CCL2 protein in wide areas around granulomas, further suggesting that CCL2 may be a critical chemokine that promotes monocyte recruitment in response to C. violaceum. In contrast, Ccl7 is expressed by fewer clusters, and to a lesser degree, and its expression is slightly delayed compared to Ccl2. Deletion of either ligand partially diminished monocyte trafficking in response to Listeria monocytogenes infection, but the individual role of each ligand was unclear (Jia et al., 2008). Future studies using C. violaceum could further elucidate the unique or redundant roles of CCL2 and CCL7. Lastly, adoptive transfer experiments in the context of Listeria infection showed that Ccr2^–/– monocytes are still able to traffic to the site of infection in the spleen (Serbina and Pamer, 2006) and liver (Shi et al., 2010). During C. violaceum infection, we have not yet determined whether CCR2 is required for migration once monocytes have left the bone marrow, as CCR2 is required for this initial egress. We saw a subtle increase in the number of macrophages in the liver of infected Ccr2^–/– mice. Though macrophage numbers in Ccr2^–/– tissues remain considerably lower than seen in WT mice, there are two explanations for the subtle increase: (1) loss of CCR2 may not completely abrogate monocyte recruitment, as monocytes could be migrating via other chemokine receptors, or (2) tissue-resident macrophages, or even tissue-resident hematopoietic stem cells, could undergo emergency hematopoiesis and proliferate in response to infection (Boettcher and Manz, 2017). More studies are needed to assess the origin of this small population of macrophages in Ccr2^–/– mice. Regardless, this small population of macrophages is not sufficient to protect against infection with C. violaceum.

In other granuloma models, the role of CCR2 is less clear. Loss of CCR2-dependent monocyte trafficking enhances clearance of Y. pseudotuberculosis (Zhang et al., 2018), which is a surprising result as typically macrophages would be expected to be important to clear infections. The role of CCR2 during M. tuberculosis infection is strain-dependent, and also varies depending on the dose and route of infection (Dunlap et al., 2018; Peters et al., 2001; Scott and Flynn, 2002). Though there are similarities between these infection models and C. violaceum, there are numerous differences. For example, expression of specific chemokines in response to M. tuberculosis differs from those we observe in response to C. violaceum, especially chemokines that attract T cells (Kang et al., 2011). A key concept in the M. tuberculosis field is that a delicate balance exists between cellular recruitment to control infection, and excess inflammation that causes disease symptoms (Monin and Khader, 2014). Furthermore, excess recruitment of monocytes to M. tuberculosis-induced granulomas leads to increased bacterial replication due to the ability of M. tuberculosis to inhibit degradation within phagosomes in which it resides (Domingo-Gonzalez et al., 2016; Slight and Khader, 2013). In contrast, C. violaceum appears to lack sufficient virulence factors to enable it to replicate within macrophages (Batista and da Silva Neto, 2017). Importantly, while M. tuberculosis bacterial burdens plateau at 21 DPI, almost all mice clear C. violaceum by this timepoint. Though decades of research have been dedicated to investigating M. tuberculosis, fewer studies involving other granuloma-inducing pathogens have been performed. As we continue to study the cellular mechanisms that allow for successful granuloma formation and clearance of C. violaceum, it will be interesting to compare the two pathogens, as future studies could shed light on key differences that result in successful pathogen clearance.

In WT mice, neutrophil recruitment wanes as the granuloma matures, which coincides with clearance of C. violaceum. However, in the Ccr2^–/– mice, we see elevated neutrophil numbers at 5 DPI, suggesting that neutrophils are continuously recruited in the absence of macrophages. Under normal circumstances, endocytosis of chemokines by endothelial cells helps to diminish chemokine gradients, limiting prolonged neutrophil recruitment (Kolaczkowska and Kubes, 2013). Future studies could investigate the various signals that diminish neutrophil recruitment in WT mice during clearance, and why this fails in Ccr2^–/– mice. Another interesting component of the granuloma response is the spatial arrangement of neutrophils and macrophages within the granuloma. In vitro studies found that CCR1 and CCR5 differentially affected monocyte localization within a transwell system, implying that a system exists for fine-tuning the exact location of macrophages within inflamed tissues (Shi and Pamer, 2011). These receptors are highly upregulated in the C. violaceum-induced granuloma and are thus good candidates for balancing the localization of macrophages between the coagulative necrosis zone and healthy tissue outside the granuloma.

Lastly, this dataset inspires a number of new hypotheses related to granuloma resolution and tissue repair after bacterial clearance. Chemokines undergo a variety of post-translational modifications, such as glycosylation, nitration, citrullination, and proteolytic cleavage, which can either enhance or abrogate their activity (Vanheule et al., 2018). For example, nitration of CCL2 and CCL3 by peroxynitrite was shown to reduce monocyte and neutrophil chemotaxis, respectively (Sato et al., 1999; Sato et al., 2000). Furthermore, binding to atypical receptors can also affect chemokine availability, representing another mechanism to resolve inflammation (Hansell et al., 2006; Ulvmar et al., 2011). Of particular interest is the implication of matrix metalloproteinases (MMPs) in regulating chemokine functions. MMPs can not only directly cleave chemokines, they can also cleave various chemokine-binding proteins that help establish the chemokine gradient (Parks et al., 2004). Several studies have found that MMPs can cleave chemokines to alter their function, either increasing or decreasing their receptor binding activity. For example, MMP-2 cleaves both CXCL12 and CCL7, abolishing their ability to induce chemotaxis (McQuibban et al., 2000; McQuibban et al., 2001); importantly, all three of these genes are upregulated during C. violaceum infection (Table 1, Table 3, Table 4). Furthermore, MMP-2 and MMP-9 have been extensively studied in the context of lung inflammation, both of which are important to limit tissue damage (Greenlee et al., 2006). MMP-9 has also been shown to promote or inhibit liver fibrosis and wound repair, depending on the context (Feng et al., 2018). An unsolved mystery during infection with C. violaceum is how the chemotaxis of neutrophils and monocytes is abrogated when the infection is cleared, and how wound repair and resolution is initiated. Future studies could characterize the role of MMPs during resolution, especially MMP-9 and its various targets in relation to wound repair.

Analysis of a spatial transcriptomics dataset revealed the upregulation of many chemokines and their receptors during murine infection with C. violaceum. Here, we show that CCR2 is an essential chemokine receptor for monocyte trafficking, which enables the formation of mature granulomas with organized macrophage zones. Importantly, loss of organized macrophages leads to loss of bacterial containment. This work has given new insight into the function of chemokines during granuloma formation, and this model of C. violaceum-induced granuloma formation will be useful in exploring the unique and redundant roles of chemokines during infection.

All study data are included in the article as source data files, and the spatial transcriptomics dataset is deposited with Dryad (https://doi.org/10.5061/dryad.zpc866thz). Streamlined RStudio code is included in Source code 1.

1. 1. Amason M
   2. Miao E
   3. Harvest C

   (2024) Dryad Digital Repository

   Spatial transcriptomics of an innate granuloma in a mouse infection model with Chromobacterium violaceum.

   https://doi.org/10.5061/dryad.zpc866thz

1. 1. Batista JH
   2. da Silva Neto JF

   (2017) Chromobacterium violaceum pathogenicity: updates and insights from genome sequencing of novel Chromobacterium species

   Frontiers in Microbiology 8:2213.

   https://doi.org/10.3389/fmicb.2017.02213

   • PubMed
   • Google Scholar
2. 1. Bertini R
   2. Allegretti M
   3. Bizzarri C
   4. Moriconi A
   5. Locati M
   6. Zampella G
   7. Cervellera MN
   8. Di Cioccio V
   9. Cesta MC
   10. Galliera E
   11. Martinez FO
   12. Di Bitondo R
   13. Troiani G
   14. Sabbatini V
   15. D’Anniballe G
   16. Anacardio R
   17. Cutrin JC
   18. Cavalieri B
   19. Mainiero F
   20. Strippoli R
   21. Villa P
   22. Di Girolamo M
   23. Martin F
   24. Gentile M
   25. Santoni A
   26. Corda D
   27. Poli G
   28. Mantovani A
   29. Ghezzi P
   30. Colotta F

   (2004) Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury

   PNAS 101:11791–11796.

   https://doi.org/10.1073/pnas.0402090101

   • PubMed
   • Google Scholar
3. 1. Boettcher S
   2. Manz MG

   (2017) Regulation of inflammation- and infection-driven hematopoiesis

   Trends in Immunology 38:345–357.

   https://doi.org/10.1016/j.it.2017.01.004

   • Google Scholar
4. 1. Bui TM
   2. Wiesolek HL
   3. Sumagin R

   (2020) ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis

   Journal of Leukocyte Biology 108:787–799.

   https://doi.org/10.1002/JLB.2MR0220-549R

   • PubMed
   • Google Scholar
5. 1. Cacalano G
   2. Lee J
   3. Kikly K
   4. Ryan AM
   5. Pitts-Meek S
   6. Hultgren B
   7. Wood WI
   8. Moore MW

   (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog

   Science 265:682–684.

   https://doi.org/10.1126/science.8036519

   • Google Scholar
6. 1. Chensue SW

   (2013) Chemokines in innate and adaptive granuloma formation

   Frontiers in Immunology 4:43.

   https://doi.org/10.3389/fimmu.2013.00043

   • PubMed
   • Google Scholar
7. 1. David BA
   2. Kubes P

   (2019) Exploring the complex role of chemokines and chemoattractants in vivo on leukocyte dynamics

   Immunological Reviews 289:9–30.

   https://doi.org/10.1111/imr.12757

   • Google Scholar
8. 1. Domingo-Gonzalez R
   2. Prince O
   3. Cooper A
   4. Khader SA

   (2016) Cytokines and chemokines in Mycobacterium tuberculosis infection

   Microbiology Spectrum 4:TBTB2-0018-2016.

   https://doi.org/10.1128/microbiolspec.TBTB2-0018-2016

   • PubMed
   • Google Scholar
9. 1. Dunlap MD
   2. Howard N
   3. Das S
   4. Scott N
   5. Ahmed M
   6. Prince O
   7. Rangel-Moreno J
   8. Rosa BA
   9. Martin J
   10. Kaushal D
   11. Kaplan G
   12. Mitreva M
   13. Kim KW
   14. Randolph GJ
   15. Khader SA

   (2018) A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis

   Mucosal Immunology 11:1727–1742.

   https://doi.org/10.1038/s41385-018-0071-y

   • PubMed
   • Google Scholar
10. 1. Feng M
    2. Ding J
    3. Wang M
    4. Zhang J
    5. Zhu X
    6. Guan W

    (2018) Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution

    International Journal of Biological Sciences 14:1033–1040.

    https://doi.org/10.7150/ijbs.25589

    • PubMed
    • Google Scholar
11. 1. Fox DJ
    2. Reckless J
    3. Lingard H
    4. Warren S
    5. Grainger DJ

    (2009) Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors

    Journal of Medicinal Chemistry 52:3591–3595.

    https://doi.org/10.1021/jm900133w

    • Google Scholar
12. 1. Greenlee KJ
    2. Corry DB
    3. Engler DA
    4. Matsunami RK
    5. Tessier P
    6. Cook RG
    7. Werb Z
    8. Kheradmand F

    (2006) Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation

    Journal of Immunology 177:7312–7321.

    https://doi.org/10.4049/jimmunol.177.10.7312

    • PubMed
    • Google Scholar
13. 1. Hafemeister C
    2. Satija R

    (2019) Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression

    Genome Biology 20:296.

    https://doi.org/10.1186/s13059-019-1874-1

    • PubMed
    • Google Scholar
14. 1. Hansell CAH
    2. Simpson CV
    3. Nibbs RJB

    (2006) Chemokine sequestration by atypical chemokine receptors

    Biochemical Society Transactions 34:1009–1013.

    https://doi.org/10.1042/BST0341009

    • Google Scholar
15. 1. Harvest CK
    2. Abele TJ
    3. Yu C
    4. Beatty CJ
    5. Amason ME
    6. Billman ZP
    7. DePrizio MA
    8. Souza FW
    9. Lacey CA
    10. Maltez VI
    11. Larson HN
    12. McGlaughon BD
    13. Saban DR
    14. Montgomery SA
    15. Miao EA

    (2023) An innate granuloma eradicates an environmental pathogen using Gsdmd and Nos2

    Nature Communications 14:6686.

    https://doi.org/10.1038/s41467-023-42218-1

    • PubMed
    • Google Scholar
16. 1. Hosoki K
    2. Sur S

    (2018) Administration of the CXCR2 inhibitor reparixin in sensitized mice inhibits allergen-challenge induced allergic inflammation

    Journal of Allergy and Clinical Immunology 141:AB281.

    https://doi.org/10.1016/j.jaci.2017.12.897

    • Google Scholar
17. 1. Hughes CE
    2. Nibbs RJB

    (2018) A guide to chemokines and their receptors

    The FEBS Journal 285:2944–2971.

    https://doi.org/10.1111/febs.14466

    • PubMed
    • Google Scholar
18. 1. Jia T
    2. Serbina NV
    3. Brandl K
    4. Zhong MX
    5. Leiner IM
    6. Charo IF
    7. Pamer EG

    (2008) Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection

    Journal of Immunology 180:6846–6853.

    https://doi.org/10.4049/jimmunol.180.10.6846

    • PubMed
    • Google Scholar
19. 1. Kang DD
    2. Lin Y
    3. Moreno JR
    4. Randall TD
    5. Khader SA

    (2011) Profiling early lung immune responses in the mouse model of tuberculosis

    PLOS ONE 6:e16161.

    https://doi.org/10.1371/journal.pone.0016161

    • PubMed
    • Google Scholar
20. 1. Kolaczkowska E
    2. Kubes P

    (2013) Neutrophil recruitment and function in health and inflammation

    Nature Reviews Immunology 13:159–175.

    https://doi.org/10.1038/nri3399

    • Google Scholar
21. 1. Kurihara T
    2. Warr G
    3. Loy J
    4. Bravo R

    (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor

    The Journal of Experimental Medicine 186:1757–1762.

    https://doi.org/10.1084/jem.186.10.1757

    • PubMed
    • Google Scholar
22. 1. Lee C
    2. Han J
    3. Jung Y

    (2023) Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver

    Experimental & Molecular Medicine 55:325–332.

    https://doi.org/10.1038/s12276-023-00941-1

    • PubMed
    • Google Scholar
23. 1. Li Y
    2. He Y
    3. Butler W
    4. Xu L
    5. Chang Y
    6. Lei K
    7. Zhang H
    8. Zhou Y
    9. Gao AC
    10. Zhang Q
    11. Taylor DG
    12. Cheng D
    13. Farber-Katz S
    14. Karam R
    15. Landrith T
    16. Li B
    17. Wu S
    18. Hsuan V
    19. Yang Q
    20. Hu H
    21. Chen X
    22. Flowers M
    23. McCall SJ
    24. Lee JK
    25. Smith BA
    26. Park JW
    27. Goldstein AS
    28. Witte ON
    29. Wang Q
    30. Rettig MB
    31. Armstrong AJ
    32. Cheng Q
    33. Huang J

    (2019) Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

    Science Translational Medicine 11:eaax0428.

    https://doi.org/10.1126/scitranslmed.aax0428

    • PubMed
    • Google Scholar
24. 1. Macher AM

    (1982) Chronic granulomatous disease of childhood and chromobacterium violaceum infections in the Southeastern United States

    Annals of Internal Medicine 97:51.

    https://doi.org/10.7326/0003-4819-97-1-51

    • Google Scholar
25. 1. Maltez VI
    2. Tubbs AL
    3. Cook KD
    4. Aachoui Y
    5. Falcone EL
    6. Holland SM
    7. Whitmire JK
    8. Miao EA

    (2015) Inflammasomes coordinate pyroptosis and natural killer cell cytotoxicity to clear infection by a ubiquitous environmental bacterium

    Immunity 43:987–997.

    https://doi.org/10.1016/j.immuni.2015.10.010

    • PubMed
    • Google Scholar
26. 1. McQuibban GA
    2. Gong JH
    3. Tam EM
    4. McCulloch CAG
    5. Clark-Lewis I
    6. Overall CM

    (2000) Inflammation dampened by gelatinase a cleavage of monocyte chemoattractant protein-3

    Science 289:1202–1206.

    https://doi.org/10.1126/science.289.5482.1202

    • Google Scholar
27. 1. McQuibban GA
    2. Butler GS
    3. Gong JH
    4. Bendall L
    5. Power C
    6. Clark-Lewis I
    7. Overall CM

    (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1

    Journal of Biological Chemistry 276:43503–43508.

    https://doi.org/10.1074/jbc.M107736200

    • Google Scholar
28. 1. Mendoza R
    2. Banerjee I
    3. Reghupaty SC
    4. Yetirajam R
    5. Manna D
    6. Sarkar D

    (2022) Isolation and culture of mouse hepatocytes and Kupffer cells (KCs)

    Methods in Molecular Biology 2455:73–84.

    https://doi.org/10.1007/978-1-0716-2128-8_7

    • PubMed
    • Google Scholar
29. 1. Mollica Poeta V
    2. Massara M
    3. Capucetti A
    4. Bonecchi R

    (2019) Chemokines and chemokine receptors: new targets for cancer immunotherapy

    Frontiers in Immunology 10:379.

    https://doi.org/10.3389/fimmu.2019.00379

    • PubMed
    • Google Scholar
30. 1. Monin L
    2. Khader SA

    (2014) Chemokines in tuberculosis: the good, the bad and the ugly

    Seminars in Immunology 26:552–558.

    https://doi.org/10.1016/j.smim.2014.09.004

    • PubMed
    • Google Scholar
31. 1. Nomiyama H
    2. Osada N
    3. Yoshie O

    (2013) Systematic classification of vertebrate chemokines based on conserved synteny and evolutionary history

    Genes to Cells 18:1–16.

    https://doi.org/10.1111/gtc.12013

    • PubMed
    • Google Scholar
32. 1. Pagán AJ
    2. Ramakrishnan L

    (2018) The formation and function of granulomas

    Annual Review of Immunology 36:639–665.

    https://doi.org/10.1146/annurev-immunol-032712-100022

    • PubMed
    • Google Scholar
33. 1. Parks WC
    2. Wilson CL
    3. López-Boado YS

    (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity

    Nature Reviews Immunology 4:617–629.

    https://doi.org/10.1038/nri1418

    • PubMed
    • Google Scholar
34. 1. Peters W
    2. Scott HM
    3. Chambers HF
    4. Flynn JL
    5. Charo IF
    6. Ernst JD

    (2001) Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis

    PNAS 98:7958–7963.

    https://doi.org/10.1073/pnas.131207398

    • PubMed
    • Google Scholar
35. 1. Saederup N
    2. Cardona AE
    3. Croft K
    4. Mizutani M
    5. Cotleur AC
    6. Tsou CL
    7. Ransohoff RM
    8. Charo IF

    (2010) Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice

    PLOS ONE 5:e13693.

    https://doi.org/10.1371/journal.pone.0013693

    • PubMed
    • Google Scholar
36. 1. Saini R
    2. Singh S

    (2018) Inducible nitric oxide synthase: an asset to neutrophils

    Journal of Leukocyte Biology 105:49–61.

    https://doi.org/10.1002/JLB.4RU0418-161R

    • PubMed
    • Google Scholar
37. 1. Sato E
    2. Simpson KL
    3. Grisham MB
    4. Koyama S
    5. Robbins RA

    (1999) Effects of reactive oxygen and nitrogen metabolites on MCP-1-induced monocyte chemotactic activity in vitro

    American Journal of Physiology-Lung Cellular and Molecular Physiology 277:L543–L549.

    https://doi.org/10.1152/ajplung.1999.277.3.L543

    • PubMed
    • Google Scholar
38. 1. Sato E
    2. Simpson KL
    3. Grisham MB
    4. Koyama S
    5. Robbins RA

    (2000) Inhibition of MIP-1α-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites

    Journal of Laboratory and Clinical Medicine 135:161–169.

    https://doi.org/10.1067/mlc.2000.104307

    • PubMed
    • Google Scholar
39. 1. Scott HM
    2. Flynn JL

    (2002) Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression

    Infection and Immunity 70:5946–5954.

    https://doi.org/10.1128/IAI.70.11.5946-5954.2002

    • PubMed
    • Google Scholar
40. 1. Serbina NV
    2. Pamer EG

    (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

    Nature Immunology 7:311–317.

    https://doi.org/10.1038/ni1309

    • PubMed
    • Google Scholar
41. 1. Shi C
    2. Velázquez P
    3. Hohl TM
    4. Leiner I
    5. Dustin ML
    6. Pamer EG

    (2010) Monocyte trafficking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression

    Journal of Immunology 184:6266–6274.

    https://doi.org/10.4049/jimmunol.0904160

    • PubMed
    • Google Scholar
42. 1. Shi C
    2. Pamer EG

    (2011) Monocyte recruitment during infection and inflammation

    Nature Reviews. Immunology 11:762–774.

    https://doi.org/10.1038/nri3070

    • PubMed
    • Google Scholar
43. 1. Slight SR
    2. Khader SA

    (2013) Chemokines shape the immune responses to tuberculosis

    Cytokine & Growth Factor Reviews 24:105–113.

    https://doi.org/10.1016/j.cytogfr.2012.10.002

    • PubMed
    • Google Scholar
44. 1. Soehnlein O
    2. Lindbom L

    (2010) Phagocyte partnership during the onset and resolution of inflammation

    Nature Reviews. Immunology 10:427–439.

    https://doi.org/10.1038/nri2779

    • PubMed
    • Google Scholar
45. 1. Sokol CL
    2. Luster AD

    (2015) The chemokine system in innate immunity

    Cold Spring Harbor Perspectives in Biology 7:a016303.

    https://doi.org/10.1101/cshperspect.a016303

    • PubMed
    • Google Scholar
46. 1. Turner MD
    2. Nedjai B
    3. Hurst T
    4. Pennington DJ

    (2014) Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

    Biochimica et Biophysica Acta - Molecular Cell Research 1843:2563–2582.

    https://doi.org/10.1016/j.bbamcr.2014.05.014

    • Google Scholar
47. 1. Ulvmar MH
    2. Hub E
    3. Rot A

    (2011) Atypical chemokine receptors

    Experimental Cell Research 317:556–568.

    https://doi.org/10.1016/j.yexcr.2011.01.012

    • PubMed
    • Google Scholar
48. 1. Vales S
    2. Kryukova J
    3. Chandra S
    4. Smagurauskaite G
    5. Payne M
    6. Clark CJ
    7. Hafner K
    8. Mburu P
    9. Denisov S
    10. Davies G
    11. Outeiral C
    12. Deane CM
    13. Morris GM
    14. Bhattacharya S

    (2023) Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling

    Nature Communications 14:5763.

    https://doi.org/10.1038/s41467-023-41488-z

    • PubMed
    • Google Scholar
49. 1. Vanheule V
    2. Metzemaekers M
    3. Janssens R
    4. Struyf S
    5. Proost P

    (2018) How post-translational modifications influence the biological activity of chemokines

    Cytokine 109:29–51.

    https://doi.org/10.1016/j.cyto.2018.02.026

    • Google Scholar
50. 1. Wang S
    2. Song R
    3. Wang Z
    4. Jing Z
    5. Wang S
    6. Ma J

    (2018) S100A8/A9 in Inflammation

    Frontiers in Immunology 9:1298.

    https://doi.org/10.3389/fimmu.2018.01298

    • PubMed
    • Google Scholar
51. 1. Warren KS

    (1976) A functional classification of granulomatous inflammation

    Annals of the New York Academy of Sciences 278:7–18.

    https://doi.org/10.1111/j.1749-6632.1976.tb47011.x

    • Google Scholar
52. 1. Zarbock A
    2. Allegretti M
    3. Ley K

    (2008) Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice

    British Journal of Pharmacology 155:357–364.

    https://doi.org/10.1038/bjp.2008.270

    • PubMed
    • Google Scholar
53. 1. Zhang Y
    2. Khairallah C
    3. Sheridan BS
    4. van der Velden AWM
    5. Bliska JB

    (2018) CCR2⁺ Inflammatory monocytes are recruited to yersinia pseudotuberculosis pyogranulomas and dictate adaptive responses at the expense of innate immunity during oral infection

    Infection and Immunity 86:e00782-17.

    https://doi.org/10.1128/IAI.00782-17

    • PubMed
    • Google Scholar
54. 1. Zlotnik A
    2. Yoshie O

    (2000) Chemokines: a new classification system and their role in immunity

    Immunity 12:121–127.

    https://doi.org/10.1016/S1074-7613(00)80165-X

    • Google Scholar
55. 1. Zlotnik A
    2. Yoshie O

    (2012) The chemokine superfamily revisited

    Immunity 36:705–716.

    https://doi.org/10.1016/j.immuni.2012.05.008

    • PubMed
    • Google Scholar

Author details

1. Megan E Amason

   1. Department of Integrative Immunobiology, Duke University School of Medicine, Durham, United States
   2. Department of Ophthalmology, Duke University School of Medicine, Durham, United States
   3. Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, United States
   4. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, United States
   5. Department of Pathology, Duke University School of Medicine, Durham, United States

   Contribution

   Data curation, Formal analysis, Software, Conceptualization, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0009-0000-2834-5834

2. Cole J Beatty

   1. Department of Integrative Immunobiology, Duke University School of Medicine, Durham, United States
   2. Department of Cell Biology, Duke University School of Medicine, Durham, United States

   Contribution

   Formal analysis, Software, Conceptualization

   Competing interests

   No competing interests declared

3. Carissa K Harvest

   1. Department of Integrative Immunobiology, Duke University School of Medicine, Durham, United States
   2. Department of Ophthalmology, Duke University School of Medicine, Durham, United States
   3. Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, United States
   4. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, United States
   5. Department of Pathology, Duke University School of Medicine, Durham, United States

   Contribution

   Formal analysis, Funding acquisition, Methodology

   Competing interests

   No competing interests declared

4. Daniel R Saban

   1. Department of Integrative Immunobiology, Duke University School of Medicine, Durham, United States
   2. Department of Cell Biology, Duke University School of Medicine, Durham, United States

   Contribution

   Supervision, Project administration

   Competing interests

   No competing interests declared

5. Edward A Miao

   1. Department of Integrative Immunobiology, Duke University School of Medicine, Durham, United States
   2. Department of Ophthalmology, Duke University School of Medicine, Durham, United States
   3. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, United States
   4. Department of Pathology, Duke University School of Medicine, Durham, United States

   Contribution

   Data curation, Supervision, Funding acquisition, Writing – review and editing

   For correspondence

   edward.miao@duke.edu

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-7295-3490

• 421

  views

• 30

  downloads

• 0

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.